BHST BioHarvest Sciences Inc

Price (delayed)

$3.2

Market cap

$72.53M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.58

Enterprise value

$66.41M

?
Relative Growth: Rel. Growth: 44
Relative Strength: Rel. Strength: 6
Relative Valuation: Rel. Valuation: 21
Relative Profitability: Rel. Profitability: 22

BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes ...

Highlights
BioHarvest Sciences's gross profit has increased by 35% YoY and by 2.2% QoQ
The revenue rose by 27% year-on-year
BHST's EPS is down by 16% year-on-year but it is up by 3.3% since the previous quarter
The net income is down by 32% YoY and by 2.7% QoQ
BHST's quick ratio is down by 28% since the previous quarter

Key stats

What are the main financial stats of BHST

BHST stock price

How has the BioHarvest Sciences stock price performed over time
Intraday
0%
1 week
0.31%
1 month
-16.67%
1 year
-58.24%
YTD
-38.34%
QTD
-26.27%

Financial performance

How have BioHarvest Sciences's revenue and profit performed over time
Revenue
$35.16M
Gross profit
$20.92M
Operating income
-$5.69M
Net income
-$11.44M
Gross margin
59.5%
Net margin
-32.5%
The operating margin has increased by 38% YoY
BioHarvest Sciences's gross profit has increased by 35% YoY and by 2.2% QoQ
The net income is down by 32% YoY and by 2.7% QoQ
The revenue rose by 27% year-on-year

Price vs fundamentals

How does BHST's price correlate with its fundamentals

Growth

What is BioHarvest Sciences's growth rate over time

Valuation

What is BioHarvest Sciences stock price valuation
P/E
N/A
P/B
3.15
P/S
2.06
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.89
BHST's EPS is down by 16% year-on-year but it is up by 3.3% since the previous quarter
BHST's equity is down by 10% since the previous quarter
The price to sales (P/S) is 43% lower than the last 4 quarters average of 3.6
The revenue rose by 27% year-on-year

Efficiency

How efficient is BioHarvest Sciences business performance
The ROE has soared by 71% year-on-year and by 45% since the previous quarter
The return on invested capital has increased by 27% year-on-year and by 7% since the previous quarter
BHST's return on sales is up by 25% year-on-year
BHST's return on assets is up by 12% year-on-year and by 10% since the previous quarter

Dividends

What is BHST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BHST.

Financial health

How did BioHarvest Sciences financials performed over time
BioHarvest Sciences's total assets is 102% more than its total liabilities
BioHarvest Sciences's total assets has soared by 71% YoY but it has decreased by 4.4% from the previous quarter
BHST's quick ratio is down by 28% since the previous quarter
BioHarvest Sciences's debt is 39% lower than its equity
BioHarvest Sciences's debt to equity has soared by 103% YoY and by 11% from the previous quarter
BioHarvest Sciences's debt has decreased by 18% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.